SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001372514-24-000053
Filing Date
2024-05-10
Accepted
2024-05-10 07:00:35
Documents
63
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q kprx-20240331.htm   iXBRL 10-Q 715398
2 EX-31.1 kprx-20240331xexx311.htm EX-31.1 7431
3 EX-31.2 kprx-20240331xexx312.htm EX-31.2 7439
4 EX-32.1 kprx-20240331xexx321.htm EX-32.1 3839
5 EX-32.2 kprx-20240331xexx322.htm EX-32.2 3836
  Complete submission text file 0001372514-24-000053.txt   5172076

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT kprx-20240331.xsd EX-101.SCH 49580
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT kprx-20240331_cal.xml EX-101.CAL 51798
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT kprx-20240331_def.xml EX-101.DEF 217620
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT kprx-20240331_lab.xml EX-101.LAB 633244
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT kprx-20240331_pre.xml EX-101.PRE 406841
67 EXTRACTED XBRL INSTANCE DOCUMENT kprx-20240331_htm.xml XML 520009
Mailing Address 332 ENCINITAS BOULEVARD SUITE 102 ENCINITAS CA 92024
Business Address 332 ENCINITAS BOULEVARD SUITE 102 ENCINITAS CA 92024 781-788-8869
KIORA PHARMACEUTICALS INC (Filer) CIK: 0001372514 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36672 | Film No.: 24932830
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)